Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update
Theratechnologies (NASDAQ: THTX) announced it will report its second-quarter financial results for fiscal 2022, ending May 31, on July 14, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies (NASDAQ: THTX) announced it will report its second-quarter financial results for fiscal 2022, ending May 31, on July 14, 2022. The company will host a conference call at 8:30 AM ET the same day, led by President and CEO Paul Lévesque, along with other executives. Participants are encouraged to join early to ensure access. Dial-in details and a webcast link will be provided for the call and replay, which will be available until July 21, 2022.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was -0.95%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, July 07, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today that it will report financial results for its second quarter of fiscal 2022 ended May 31 on Thursday, July 14, 2022.
The conference call will be held on July 14, 2022 at 8:30 a.m. (ET) to discuss the results and recent business updates. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Philippe Dubuc and Chief Medical Officer Christian Marsolais, who will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call ten minutes in advance to secure access.
Conference call dial-in and replay information is below:
| CONFERENCE CALL INFORMATION | |
| Conference Call Date: | July 14, 2022 |
| Conference Call Time: | 8:30 AM ET |
| North America Dial-in: | 1- 877-513-4119 |
| International Dial-in: | 1- 412-902-6615 |
| Access Code: | 5742327 |
| CONFERENCE CALL REPLAY | |
| North America Dial-in: | 1- 877-344-7529 |
| International Dial-in: | 1- 412-317-0088 |
| Replay Access Code: | 7192794 |
| Replay End Date | July 21, 2022 |
The live conference call will be accessible via webcast at: https://edge.media-server.com/mmc/p/98pvag4g.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
Investors:
Elif McDonald
Senior Director, Investor Relations
1-438-315-8563
ir@theratech.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.